Taysha Gene Therapies, Inc.

Q4 2025 13F Holders

Symbol
TSHA
CUSIP
877619106
Type
Equity
Class
COM SHS
Num filings
210
Total reported value, excl. options
$1.48 B
Manager Report Date Value ($000) Shares Option Type